Solactive is pleased to further strengthen its collaboration with Ping An of China Asset Management (Hong Kong) Company Limited (“Ping An Asset Management
(Hong Kong)”) with the launch of two new ETFs. The Ping An Healthcare 50 Select ETF tracks the Solactive G2 Healthcare 50 Select Index, while the Ping An AI Select ETF tracks the Solactive G2 Artificial Intelligence Select Index.
Healthcare markets continue to evolve alongside advances in medical technology, changing demographic needs, and developments in the delivery of care. Across Hong Kong, China, and the United States, healthcare companies operate across areas ranging from pharmaceuticals and biotechnology to medical technology and healthcare services, reflecting the breadth and continued evolution of the sector.
The Solactive G2 Healthcare 50 Select Index captures leading healthcare companies listed in Hong Kong and the United States. Its eligible universe is subject to minimum size and liquidity requirements and focuses on securities classified within the healthcare sector. The final composition comprises up to 30 Hong Kong-listed and up to 20 U.S.-listed companies, selected by free-float market capitalization. Hong Kong-listed securities must additionally be eligible for Southbound Trading through the Shanghai-Hong Kong or Shenzhen-Hong Kong Stock Connect programs. Constituents are weighted by free-float market capitalization, with 62% allocated to Hong Kong-listed securities and 38% to U.S.-listed securities. Individual Hong Kong-listed constituents are capped at 8% and U.S.-listed constituents at 5%, while the five largest components may together account for no more than 55% of the index. The index is rebalanced quarterly.
Artificial intelligence is undergoing rapid development as its use expands across computing infrastructure, software platforms, and a growing range of applications. Continued developments in areas such as semiconductors, data infrastructure, AI platforms, and application software are contributing to the evolution of the AI ecosystem across the United States and Asia.
The Solactive G2 Artificial Intelligence Select Index provides exposure to companies associated with the artificial intelligence sector across the Hong Kong and U.S. equity markets. Companies are identified across three AI exposure buckets: AI Infrastructure, AI Platforms, and AI Applications. Following the application of liquidity requirements, eligible securities are ranked by free-float market capitalization, resulting in the selection of up to 20 Hong Kong-listed companies and up to 40 U.S.-listed companies. The index assigns 62% of its weight to eligible Hong Kong-listed constituents and 38% to U.S.-listed constituents, with each individual security capped at 10%. The index is rebalanced quarterly.
The ETFs were listed on 30 September 2026 on the Hong Kong Stock Exchange under the following information,
| ETF | TICKER |
|---|---|
| Ping An Healthcare 50 Select ETF | 03500.HK (HKD), 41500.HK (USD) |
| Ping An AI Select ETF | 03510.HK (HKD), 41510.HK (USD) |
Timo Pfeiffer, Chief Markets Officer at Solactive, commented: “We are pleased to deepen our collaboration with Ping An Asset Management (Hong Kong) with the launch of these two ETFs. Both healthcare and artificial intelligence continue to evolve rapidly, underscoring the importance of transparent and rules-based index solutions that reflect developments within these markets. We are delighted to support Ping An Asset Management (Hong Kong) with indices tailored to these distinct investment themes.”
Mr. Albert Wang, Head of Capital Markets and CIO of PAAMC HK, said: “As technological breakthroughs drive growth across the AI value chain, the Ping An AI Select ETF spans AI infrastructure, platforms and applications, diversifying exposure across technological pathways while capturing innovation-led opportunities. The Ping An Healthcare 50 Select ETF focuses on Chinese pharmaceutical companies spearheading global expansion and U.S. leaders in innovative medicines, offering one-stop access to the sector’s long-term global growth potential. We are delighted to launch these two ETFs with the support of Solactive, broadening investment choices for investors seeking to capture compelling growth opportunities in the global AI and healthcare sectors.”
